Through CRISPR-barcoding, we inserted a short stretch of degenerated nucleotides in a safe harbor genomic locus of a NSCLC cell line, and we investigated the effects on the clonal architecture induced by EGFR-TKI treatment [114]. Here, EGFR is linked to non-small cell lung carcinoma.